Paper7755232
Fixed-dose combinations of antituberculous medications to prevent drug resistance.
Moulding T and 2 others. Ann Intern Med, 1995. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Fixed-dose combinations of antituberculous medications to prevent drug resistance. Papers, record 7755232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7755232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Drug Combinations | |
| Drug Resistance, Microbial | |
| Humans | |
| Isoniazid | |
| Pyrazinamide | |
| Rifampin |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 200-93-0636 | PHS HHS | United States | PubMed | |
| 200-93-0690 | PHS HHS | United States | PubMed | |
| K07-H103015-01 | PHS HHS | United States | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 7755233 | Tuberculosis: yesterday, today, and tomorrow. | https://conductscience.org/library/papers/7755233 |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37507108 | Orthogonal Gelations to Synthesize Core-Shell Hydrogels Loaded with Nanoemulsion-Templated Drug Nanoparticles for Versatile Oral Drug Delivery. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37507108 | PubMed |
| 28959585 | The combined fixed-dose antituberculous drugs alter some reproductive functions with oxidative stress involvement in wistar rats. | Toxicol Rep | 2016 | https://conductscience.org/library/papers/28959585 | PubMed |
| 27516382 | Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27516382 | PubMed |
| 26966383 | Patient considerations in type 2 diabetes - role of combination dapagliflozin-metformin XR. | Diabetes Metab Syndr Obes | 2016 | https://conductscience.org/library/papers/26966383 | PubMed |
| 26550490 | Single Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in Australia. | AIDS Res Treat | 2015 | https://conductscience.org/library/papers/26550490 | PubMed |
| 26106962 | Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment. | Clinics (Sao Paulo) | 2015 | https://conductscience.org/library/papers/26106962 | PubMed |
| 24596613 | Tuberculosis of spine: current views in diagnosis and management. | Asian Spine J | 2014 | https://conductscience.org/library/papers/24596613 | PubMed |
| 22151609 | Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. | BMC Public Health | 2011 | https://conductscience.org/library/papers/22151609 | PubMed |
| 21439089 | Driving a decade of change: HIV/AIDS, patents and access to medicines for all. | J Int AIDS Soc | 2011 | https://conductscience.org/library/papers/21439089 | PubMed |
| 20500827 | Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. | Global Health | 2010 | https://conductscience.org/library/papers/20500827 | PubMed |
| 19621068 | Focusing on quality patient care in the new global subsidy for malaria medicines. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621068 | PubMed |
| 12219687 | [Tuberculosis]. | Internist (Berl) | 2002 | https://conductscience.org/library/papers/12219687 | PubMed |
| 8987432 | Multidrug-resistant tuberculosis--how far are we from New York City? | West J Med | 1996 | https://conductscience.org/library/papers/8987432 | PubMed |
| 8736627 | Tuberculosis in the elderly. Epidemiology and optimal management. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8736627 | PubMed |
| 8725999 | Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8725999 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7755232
GET https://conductscience.org/api/papers/v1/7755232/authors